Hasegawa Y - Search Results

1

A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141.

Kiyota N, Hasegawa Y, Takahashi S, Yokota T, Yen CJ, Iwae S, Shimizu Y, Hong RL, Goto M, Kang JH, Sum Kenneth Li W, Ferris RL, Gillison M, Namba Y, Monga M, Lynch M, Tahara M. Kiyota N, et al. Among authors: hasegawa y. Oral Oncol. 2017 Oct;73:138-146. doi: 10.1016/j.oraloncology.2017.07.023. Epub 2017 Sep 1. Oral Oncol. 2017. PMID: 28939066 Free article. Clinical Trial.

2

[Chemo-radiotherapy for head and neck cancer].

Hasegawa Y. Hasegawa Y. Gan To Kagaku Ryoho. 2002 May;29(5):677-83. Gan To Kagaku Ryoho. 2002. PMID: 12040670 Review. Japanese.

3

Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers.

Goto M, Hasegawa Y, Terada A, Hyodo I, Hanai N, Ijichi K, Yamada H, Fujimoto Y, Ogawa T. Goto M, et al. Among authors: hasegawa y. Oral Oncol. 2005 Jan;41(1):62-9. doi: 10.1016/j.oraloncology.2004.06.007. Oral Oncol. 2005. PMID: 15598587

4

[A Phase I study of docetaxel and cisplatin for advanced squamous cell carcinoma of the head and neck].

Ogawa T, Terada A, Hyodo I, Ando A, Suzuki Y, Ozawa T, Hasegawa Y. Ogawa T, et al. Among authors: hasegawa y. Gan To Kagaku Ryoho. 2005 Jul;32(7):977-81. Gan To Kagaku Ryoho. 2005. PMID: 16044959 Clinical Trial. Japanese.

5

Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.

Hasegawa Y, Goto M, Hanai N, Ijichi K, Adachi M, Terada A, Hyodo I, Ogawa T, Furukawa T. Hasegawa Y, et al. Oral Oncol. 2007 Sep;43(8):749-56. doi: 10.1016/j.oraloncology.2006.09.003. Epub 2006 Nov 16. Oral Oncol. 2007. PMID: 17112769

6

[Salvage surgery for radiation failure in oral, oropharyngeal, and hypopharyngeal squamous cell carcinoma].

Suzuki M, Terada A, Ogawa T, Suzuki H, Hasegawa Y. Suzuki M, et al. Among authors: hasegawa y. Nihon Jibiinkoka Gakkai Kaiho. 2007 Jun;110(6):461-5. doi: 10.3950/jibiinkoka.110.461. Nihon Jibiinkoka Gakkai Kaiho. 2007. PMID: 17633115 Japanese.

7

[Detection of FDG-PET and FDG-PET/CT in head and neck squamous cell carcinoma].

Suzuki H, Ogawa T, Terada A, Arima S, Ozawa T, Suzuki M, Nakashima T, Tamaki T, Nishio M, Hasegawa Y. Suzuki H, et al. Among authors: hasegawa y. Nihon Jibiinkoka Gakkai Kaiho. 2007 Sep;110(9):629-34. doi: 10.3950/jibiinkoka.110.629. Nihon Jibiinkoka Gakkai Kaiho. 2007. PMID: 17966497 Japanese.

8

Intraoperative diagnosis of cancer metastasis in sentinel lymph node of oral cancer patients.

Terada A, Hasegawa Y, Yatabe Y, Hyodo I, Ogawa T, Hanai N, Ikeda A, Nagashima Y, Masui T, Hirakawa H, Nakashima T. Terada A, et al. Among authors: hasegawa y. Oral Oncol. 2008 Sep;44(9):838-43. doi: 10.1016/j.oraloncology.2007.11.006. Epub 2008 Jan 29. Oral Oncol. 2008. PMID: 18234545

9

Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.

Hasegawa Y, Goto M, Hanai N, Ijichi K, Terada A, Hyodo I, Ogawa T, Fukushima M. Hasegawa Y, et al. Oncology. 2007;73(1-2):104-11. doi: 10.1159/000120998. Epub 2008 Mar 13. Oncology. 2007. PMID: 18337622

10

FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma.

Suzuki H, Hasegawa Y, Terada A, Hyodo I, Nakashima T, Nishio M, Tamaki T. Suzuki H, et al. Among authors: hasegawa y. Oral Oncol. 2009 Jul;45(7):569-73. doi: 10.1016/j.oraloncology.2008.07.009. Epub 2008 Sep 18. Oral Oncol. 2009. PMID: 18804407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,813 results

Search Page

Filters